A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm

Concurrent use of cocaine and heroin is a major public health issue with no effective relapse prevention treatment currently available. To this purpose, a combination of buprenorphine and naltrexone, a mixed very-low efficacy mu-opioid receptor agonist/kappa-opioid receptor antagonist/nociceptin rec...

Full description

Bibliographic Details
Main Authors: Cordery, Sarah F, Taverner, Alistair, Ridzwan, Irna Elina, Guy, Richard H, Delgado-Charro, M Begoña, Husbands, Stephen M, Bailey, Christopher P
Format: Article
Language:English
Published: Wiley 2014
Subjects:
Online Access:http://irep.iium.edu.my/35174/
http://irep.iium.edu.my/35174/1/35174.pdf
_version_ 1848781018240122880
author Cordery, Sarah F
Taverner, Alistair
Ridzwan, Irna Elina
Guy, Richard H
Delgado-Charro, M Begoña
Husbands, Stephen M
Bailey, Christopher P
author_facet Cordery, Sarah F
Taverner, Alistair
Ridzwan, Irna Elina
Guy, Richard H
Delgado-Charro, M Begoña
Husbands, Stephen M
Bailey, Christopher P
author_sort Cordery, Sarah F
building IIUM Repository
collection Online Access
description Concurrent use of cocaine and heroin is a major public health issue with no effective relapse prevention treatment currently available. To this purpose, a combination of buprenorphine and naltrexone, a mixed very-low efficacy mu-opioid receptor agonist/kappa-opioid receptor antagonist/nociceptin receptor agonist, was investigated. The tail-withdrawal and the conditioned place preference (CPP) assays in adult Sprague Dawley rats were used to show that naltrexone dose-dependently blocked the mu-opioid receptor agonism of buprenorphine. Furthermore, in the CPP assay, a combination of 0.3 mg/kg buprenorphine and 3.0 mg/kg naltrexone was aversive. A combination of 0.3 mg/kg buprenorphine and 1.0 mg/kg naltrexone was neither rewarding nor aversive, but still possessed mu-opioid receptor antagonist properties. In the CPP extinction and reinstatement method, a combination of 0.3 mg/kg buprenorphine and 1.0 mg/kg naltrexone completely blocked drug-primed reinstatement in cocaine-conditioned rats (conditioned with 3 mg/kg cocaine, drug prime was 3 mg/kg cocaine) and attenuated drug-primed reinstatement in morphine-conditioned rats (conditioned with 5 mg/kg morphine, drug prime was 1.25 mg/kg morphine). These data add to the growing evidence that a buprenorphine/naltrexone combination may be protective against relapse in a polydrug abuse situation.
first_indexed 2025-11-14T15:42:53Z
format Article
id iium-35174
institution International Islamic University Malaysia
institution_category Local University
language English
last_indexed 2025-11-14T15:42:53Z
publishDate 2014
publisher Wiley
recordtype eprints
repository_type Digital Repository
spelling iium-351742018-08-08T04:19:21Z http://irep.iium.edu.my/35174/ A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm Cordery, Sarah F Taverner, Alistair Ridzwan, Irna Elina Guy, Richard H Delgado-Charro, M Begoña Husbands, Stephen M Bailey, Christopher P RM300 Drugs and their action RS Pharmacy and materia medica Concurrent use of cocaine and heroin is a major public health issue with no effective relapse prevention treatment currently available. To this purpose, a combination of buprenorphine and naltrexone, a mixed very-low efficacy mu-opioid receptor agonist/kappa-opioid receptor antagonist/nociceptin receptor agonist, was investigated. The tail-withdrawal and the conditioned place preference (CPP) assays in adult Sprague Dawley rats were used to show that naltrexone dose-dependently blocked the mu-opioid receptor agonism of buprenorphine. Furthermore, in the CPP assay, a combination of 0.3 mg/kg buprenorphine and 3.0 mg/kg naltrexone was aversive. A combination of 0.3 mg/kg buprenorphine and 1.0 mg/kg naltrexone was neither rewarding nor aversive, but still possessed mu-opioid receptor antagonist properties. In the CPP extinction and reinstatement method, a combination of 0.3 mg/kg buprenorphine and 1.0 mg/kg naltrexone completely blocked drug-primed reinstatement in cocaine-conditioned rats (conditioned with 3 mg/kg cocaine, drug prime was 3 mg/kg cocaine) and attenuated drug-primed reinstatement in morphine-conditioned rats (conditioned with 5 mg/kg morphine, drug prime was 1.25 mg/kg morphine). These data add to the growing evidence that a buprenorphine/naltrexone combination may be protective against relapse in a polydrug abuse situation. Wiley 2014-07 Article PeerReviewed application/pdf en http://irep.iium.edu.my/35174/1/35174.pdf Cordery, Sarah F and Taverner, Alistair and Ridzwan, Irna Elina and Guy, Richard H and Delgado-Charro, M Begoña and Husbands, Stephen M and Bailey, Christopher P (2014) A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm. Addiction Biology, 19 (4). pp. 575-586. ISSN 1355-6215 E-ISSN 1369-1600 https://onlinelibrary.wiley.com/toc/13691600/2014/19/4
spellingShingle RM300 Drugs and their action
RS Pharmacy and materia medica
Cordery, Sarah F
Taverner, Alistair
Ridzwan, Irna Elina
Guy, Richard H
Delgado-Charro, M Begoña
Husbands, Stephen M
Bailey, Christopher P
A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm
title A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm
title_full A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm
title_fullStr A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm
title_full_unstemmed A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm
title_short A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm
title_sort non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm
topic RM300 Drugs and their action
RS Pharmacy and materia medica
url http://irep.iium.edu.my/35174/
http://irep.iium.edu.my/35174/
http://irep.iium.edu.my/35174/1/35174.pdf